Ident. | Authors (with country if any) | Title |
---|
000225 |
Amit Bar-Or [Canada] ; Peter Rieckmann [Canada] ; Anthony Traboulsee [Canada] ; V. Wee Yong [Canada] | Targeting Progressive Neuroaxonal Injury: Lessons from Multiple Sclerosis |
000528 |
J.-F. Gagnon [Canada] ; D. Petit [Canada] ; V. Latreille [Canada] ; J. Montplaisir [Canada] | Neurobiology of Sleep Disturbances in Neurodegenerative Disorders |
000564 |
Alison Fenney [Canada] ; Mandar S. Jog [Canada] ; Christian Duval [Canada] | Bradykinesia is not a "systematic" feature of adult-onset Huntington's disease; implications for basal ganglia pathophysiology |
000656 |
M. Berk [Australie] ; S. Dodd [Australie] ; M. Kauer-Sant'Anna [Canada] ; G. S. Malhi [Australie] ; M. Bourin [France] ; F. Kapczinski [Brésil] ; T. Norman [Australie] | Dopamine dysregulation syndrome : implications for a dopamine hypothesis of bipolar disorder |
000685 |
Fannie St-Gelais [Canada] ; Claudia Jomphe [Canada] ; Louis-Eric Trudeau [Canada] | The role of neurotensin in central nervous system pathophysiology : What is the evidence? |
000777 |
John R. Adams [Canada] ; Hinke Van Netten [Canada] ; Michael Schulzer [Canada] ; Edwin Mak [Canada] ; Jessamyn Mckenzie [Canada] ; Audrey Strongosky [États-Unis] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; Chong S. Lee [Canada] ; Matthew Farrer [États-Unis] ; Thomas Gasser [Allemagne] ; Ryan J. Uitti [États-Unis] ; Donald B. Calne [Canada] ; Zbigniew K. Wszolek [États-Unis] ; A. Jon Stoessl [Canada] | PET in LRRK2 mutations : comparison to sporadic parkinson's disease and evidence for presymptomatic compensation |
000778 |
Ash Kishore [Canada] ; Anthony E. Lang [Canada] | Normalization of voice in spasmodic dysphonia during transient global amnesia |
000845 |
Dominique Petit [Canada] ; Jean-Francois Gagnon [Canada] ; Maria Livia Fantini [Canada] ; Luigi Ferini-Strambi [Italie] ; Jacques Montplaisir [Canada] | Sleep and quantitative EEG in neurodegenerative disorders |
000910 |
Pierre J. Blanchet [Canada] | The fluctuating Parkinsonian patient: Clinical and pathophysiological aspects |
000946 |
Lisa M. Inkster [Canada] ; Janice J. Eng [Canada] ; Donna L. Macintyre [Canada] ; A. Jon Stoessl [Canada] | Leg muscle strength is reduced in Parkinson's disease and relates to the ability to rise from a chair |
000954 |
Kelly L. Jordan-Sciutto [États-Unis] ; Robert Dorsey [États-Unis] ; Elisabeth M. Chalovich [États-Unis] ; Robert R. Hammond [Canada] ; Cristian L. Achim [États-Unis] | Expression patterns of retinoblastoma protein in Parkinson disease |
000960 |
Stephen Hague [Canada] ; Ekaterina Rogaeva [Canada] ; Dena Hernandez [Canada] ; Cindy Gulick [Canada] ; Amanda Singleton [États-Unis] ; Melissa Hanson [États-Unis] ; Janel Johnson [Canada] ; Roberto Weiser [Venezuela] ; Marisol Gallardo [Venezuela] ; Bernard Ravina [États-Unis] ; Katrina Gwinn-Hardy [États-Unis] ; Anthony Crawley [États-Unis] ; Peter H. St. George-Hyslop [Canada] ; Anthony E. Lang [Canada] ; Peter Heutink [Pays-Bas] ; Vincenzo Bonifati [Pays-Bas, Italie] ; John Hardy [États-Unis] ; Andrew Singleton [Canada] | Early-onset Parkinson's disease caused by a compound heterozygous DJ-1 mutation |
000981 |
J.-F. Gagnon [Canada] ; J. Montplaisir [Canada] ; M.-A. Bedard [Canada] | Les troubles du sommeil paradoxal dans la maladie de Parkinson |
000983 |
A. Beuter [Canada] ; R. Edwards [Canada] | Caractérisation et discrimination du tremblement cinétique dans la maladie de Parkinson |
000A22 |
Michel Cyr [Canada] ; Frederic Calon [Canada] ; Marc Morissette [Canada] ; Thérèse Di Paolo [Canada] | Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease |
000A35 |
Francois Tremblay [Canada] ; Louis E. Tremblay [Canada] | Cortico-motor excitability of the lower limb motor representation: a comparative study in Parkinson's disease and healthy controls |
000A47 |
Jean-Pierre Melun [Canada] ; Louise M. Morin [Canada] ; J. Gerard Muise [Canada] ; Marc Desrosiers [Canada] | Color vision deficiencies in Gilles de la Tourette syndrome |
000A52 |
Alain Dagher [Royaume-Uni, Canada] ; Adrian M. Owen [Royaume-Uni] ; Henning Boecker [Royaume-Uni] ; David J. Brooks [Royaume-Uni] | The role of the striatum and hippocampus in planning : A PET activation study in Parkinson's disease |
000A61 |
Thomas N. Chase [États-Unis] ; Spiridon Konitsiotis [États-Unis] ; Justin D. Oh [États-Unis] | Striatal molecular mechanisms and motor dysfunction in Parkinson's disease |
000A81 |
K. Yasojima [Canada] ; W. W. Tourtellotte [États-Unis] ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | Marked increase in cyclooxygenase-2 in ALS spinal cord: Implications for therapy |
000B02 |
John Woulfe [Canada] ; Andrew Kertesz [Canada] ; David G. Munoz [Canada, Espagne] | Frontotemporal dementia with ubiquitinated cytoplasmic and intranuclear inclusions |
000B28 |
Lüder Deecke [Autriche] | Clinical neurophysiology of Parkinson's disease: Bereitschaftspotential and contingent negative variation |
000B29 |
David J. Brooks [Royaume-Uni] | Cerebral blood flow activation studies in Parkinson's disease |
000B35 |
Lana Depatie [Canada] ; Samarthji Lal [Canada] | Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma? |
000B65 |
M. Filion [Canada] ; OBESO ; BENABID ; OLANOW ; LANG ; HIRSCH ; NUTT | Physiologic basis of dyskinesia. Discussion |
000B67 |
Duong P. Huynh [États-Unis] ; Daniel R. Scoles [États-Unis] ; Trang H. Ho [États-Unis] ; Marc R. Del Bigio [Canada] ; Stefan-M. Pulst [États-Unis] | Parkin is associated with actin filaments in neuronal and nonneural cells |
000B81 |
F. Calon [Canada] ; R. Grondin [Canada] ; M. Morissette [Canada] ; M. Goulet [Canada] ; P. J. Blanchet [Canada] ; T. T. Di Paolo [Canada] ; P. J. Bedard [Canada] | Molecular basis of levodopa-induced dyskinesias |
000C11 |
O. Monchi [Canada] ; J. G. Taylor [Royaume-Uni] ; A. Dagher [Canada] | A neural model of working memory processes in normal subjects, Parkinson's disease and schizophrenia for fMRI design and predictions |
000C57 |
G. Flores [Mexique, Canada] ; J. J. Liang [Mexique, Canada] ; A. Sierra [Mexique] ; D. Martinez-Fong [Mexique] ; R. Quirion [Mexique, Canada] ; J. Aceves [Mexique] ; L. K. Srivastava [Mexique] | Expression of dopamine receptors in the subthalamic nucleus of the rat : Characterization using reverse transcriptase-polymerase chain reaction and autoradiography |
000C91 |
A. E. Lang [Canada] ; A. M. Lozano [Canada] | Parkinson's disease: First of two parts |
000D12 |
P. L. Mcgeer [Canada] ; E. G. Mcgeer [Canada] | Glial cell reactions in neurodegenerative diseases : Pathophysiology and therapeutic interventions |
000D47 |
A. Parent [Canada] ; F. Cicchetti [Canada] | Anatomie et physiopathologie des ganglions de la base |
000D57 |
N. Paquet [Canada] ; C. W. Y. Hui-Chan [Canada] | Responses to dynamic head-and-body tilts are enhanced in Parkinson's disease |
000D80 |
W. D. Hutchison [Canada] ; A. M. Lozano [Canada] ; R. R. Tasker [Canada] ; A. E. Lang [Canada] ; J. O. Dostrovsky [Canada] | Identification and characterization of neurons with tremor-frequency activity in human globus pallidus |
000E33 |
J. M. Wilson [Canada] ; A. I. Levey [États-Unis] ; A. Rajput [Canada] ; L. Ang [Canada] ; M. Guttman [Canada] ; K. Shannak [Canada] ; H. B. Niznik [Canada] ; O. Hornykiewicz [Canada, Autriche] ; C. Pifl [Autriche] ; S. J. Kish [Canada] | Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease |
000E39 |
F. Q. Ye [Canada] ; P. S. Allen [Canada] ; W. R. W. Martin | Basal ganglia iron content in Parkinson's disease measured with magnetic resonance |
000E40 |
B. P. Connop [Canada] ; R. J. Boegman [Canada] ; R. J. Beninger ; K. Jhamandas [Canada] | Attenuation of malonate-induced degeneration of the nigrostriatal pathway by inhibitors of nitric oxide synthase |
000E51 |
C. Schwab [Canada] ; J. C. Steele ; H. Akiyama ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | Relationship of amyloid β/A4 protein to the neurofibrillary tangles in Guamanian parkinsonism-dementia |
000E55 |
R. G. Lee [Canada] ; I. Tonolli [France] ; F. Viallet [France] ; R. Aurenty [France] ; J. Massion [France] | Preparatory postural adjustments in Parkinsonian patients with postural instability |
000E59 |
E. Mohr [Canada] ; T. Mendis ; J. D. Grimes | Late cognitive changes in Parkinson's disease with an emphasis on dementia |
000E70 |
P. Chagnon [Canada] ; C. Betard ; Y. Robitaille ; A. Cholette ; D. Gauvreau | Distribution of brain cytochrome oxidase activity in various neurodegenerative diseases |
000E72 |
P. J. Bedard [Canada] | D-1 receptor in neurology and psychiatry : an overview : The role of D-1 dopamine receptors in neurology and psychiatry |
000E77 |
M.-G. Martinoli [Canada] ; J. Q. Trojanowski ; M. L. Schmidt ; S. E. Arnold ; T. M. Fujiwara ; V. M.-Y. Lee ; H. Hurtig ; J.-P. Julien [Canada] ; C. Clark | Association of apolipoprotein ε4 allele and neuropathologic findings in patients with dementia |
000E82 |
| |
000E91 |
J. P. Hammerstad [Canada] ; K. Elliott ; E. Mak ; M. Schulzer ; S. Calne ; D. B. Calne | Tendon jerks in Parkinson's disease |
000E98 |
B. P. Connop [Canada] ; N. G. Rolfe ; R. J. Boegman [Canada] ; K. Jhamandas [Canada] ; R. J. Beninger | Potentiation of NMDA-mediated toxicity on nigrostriatal neurons by a low dose of 7-nitro indazole |
000F33 |
D. S. Borrett [Canada] ; T. H. Yeap ; H. C. Kwan | Neural networks and Parkinson's disease |
000F38 |
M. Wathen [Canada] ; A. Natale ; K. Wolfe ; R. Yee ; G. Klein | Initiation of atrial fibrillation in the Wolff-Parkinson-White syndrome : the importance of the accessory pathway |
000F52 |
A. P. Sen [Canada] ; P. Boksa ; R. Quirion | Brain calcium channel related dihydropyridine and phenylalkylamine binding sites in Alzheimer's, Parkinson's and Huntington's diseases |
000F58 |
A. J. Flint [Canada] ; S. E. Black ; I. Campbell-Taylor ; G. F. Gailey ; C. Levinton | Abnormal speech articulation, psychomotor retardation, and subcortical dysfunction in major depression |
000F61 |
| 3 rd Canadian conference on neurodegenerative diseases, L'Estérel PQ, April 4-6, 1991 |
000F74 |
J. Kalra [Canada] ; A. H. Rajput ; S. V. Mantha ; K. Prasad | Serum antioxidant enzyme activity in Parkinson's disease |
000F91 |
B. Gomez-Mancilla [Canada] ; P. J. Bedard | Effect of chronic treatment with (+)-PHNO, a D2 agonist in MPTP-treated monkeys |
000F95 |
J. L. Cummings [Canada] | Depression and Parkinson's disease : a review |
001010 |
M. Cordes [Canada] ; B. J. Snow ; H. Takahashi ; P. Schofield ; S. Cooper ; V. Sossi ; S. Morrison ; D. B. Calne | L-18F-DOPA-PET bei Parkinson-Plus-Syndromen zum Nachweis einer gestörten präsynaptischen dopaminergen Funktion |
001033 |
D. B. Calne ; M. J. Zigmond | Compensatory mechanisms in degenerative neurologic diseases : insights from Parkinsonism |
001043 |
S. J. Kish ; L. M. Distefano ; S. Dozic ; Y. Robitaille ; A. Rajput ; J. H. N. Deck ; O. Hornykiewicz | [3H]vesamicol binding in human brain cholinergic deficiency disorders |
001096 |
P. J. Bedard ; R. Boucher | Effect of D1 receptor stimulation in normal and MPTP monkeys |
001175 |
J. Kish ; A. Rajput ; J. Gilbert ; B. Rozdilsky ; L.-J. Chang ; K. Shannak ; O. Hornykiewicz | Elevated γ-aminobutyric acid level in striatal but not extrastriatal brain regions in Parkinson's disease: correlation with striatal dopamine loss |